These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activation of NF-κB by TOPK upregulates Snail/Slug expression in TGF-β1 signaling to induce epithelial-mesenchymal transition and invasion of breast cancer cells. Lee YJ; Park JH; Oh SM Biochem Biophys Res Commun; 2020 Sep; 530(1):122-129. PubMed ID: 32828273 [TBL] [Abstract][Full Text] [Related]
3. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
4. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma. Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486 [TBL] [Abstract][Full Text] [Related]
5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
6. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition. Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783 [TBL] [Abstract][Full Text] [Related]
7. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057 [TBL] [Abstract][Full Text] [Related]
8. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation. Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386 [TBL] [Abstract][Full Text] [Related]
9. SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma. Bossart EA; Tasdemir N; Sikora MJ; Bahreini A; Levine KM; Chen J; Basudan A; Jacobsen BM; Burns TF; Oesterreich S Breast Cancer Res Treat; 2019 Jun; 175(2):327-337. PubMed ID: 30798422 [TBL] [Abstract][Full Text] [Related]
10. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells. Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782 [TBL] [Abstract][Full Text] [Related]
11. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
12. Voltage-gated sodium channel Na Sui Q; Peng J; Han K; Lin J; Zhang R; Ou Q; Qin J; Deng Y; Zhou W; Kong L; Tang J; Xiao B; Li Y; Yu L; Fang Y; Ding PR; Pan Z Cancer Lett; 2021 Mar; 500():119-131. PubMed ID: 33338532 [TBL] [Abstract][Full Text] [Related]
13. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
15. PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model. Chiang KC; Hsu SY; Lin SJ; Yeh CN; Pang JH; Wang SY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Cheng YC; Juang HH Anticancer Res; 2016 Aug; 36(8):3997-4005. PubMed ID: 27466505 [TBL] [Abstract][Full Text] [Related]
16. Epithelial to mesenchymal transition is associated with rapamycin resistance. Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619 [TBL] [Abstract][Full Text] [Related]
17. Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness. Chen Y; Sumardika IW; Tomonobu N; Kinoshita R; Inoue Y; Iioka H; Mitsui Y; Saito K; Ruma IMW; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Kubo M; Putranto EW; Murakami T; Liu M; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M Neoplasia; 2019 Jul; 21(7):627-640. PubMed ID: 31100639 [TBL] [Abstract][Full Text] [Related]
18. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397 [TBL] [Abstract][Full Text] [Related]
19. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration. Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803 [TBL] [Abstract][Full Text] [Related]
20. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation. Wang M; Zhao F; Li S; Chang AK; Jia Z; Chen Y; Xu F; Pan H; Wu H PLoS One; 2013; 8(6):e65556. PubMed ID: 23762395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]